BROOKE COUNCE: Open Payments
NPI 1922630417 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,905 in 135 payments from 23 companies in 2025. Trend: 2023 $3,403 · 2024 $2,110 · 2025 $2,905
Food & beverage: $2,899Education: $6
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $436 |
| GlaxoSmithKline, LLC. | 20 | $411 |
| Verona Pharma, Inc. | 10 | $235 |
| GENZYME CORPORATION | 10 | $199 |
| Regeneron Healthcare Solutions, Inc. | 10 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $177 |
| Insmed, Inc. | 9 | $158 |
| Grifols USA, LLC | 5 | $143 |
| United Therapeutics Corporation | 5 | $130 |
| Merck Sharp & Dohme LLC | 5 | $96 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, FASENRA, Arikayce, Prolastin-C Liquid, Tyvaso, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
